Nardev Ramanathan leads Lux Research’s coverage of Digital Health and Wellness and is a key contributor to the Digital Transformation team, where he more broadly supports the coverage of new and emerging digital trends and innovations. Nardev has deep expertise in health IoT, digital therapeutics, precision medicine, and genomics.
Prior to joining Lux, Nardev was the assistant head of the Industrial Development Group at the Agency for Science, Technology and Research (A*STAR), Singapore, where he was the precision medicine and digital health lead. In that role, he helped develop an industry consortium to support Singapore’s biotech ecosystem for precision-medicine-related initiatives.
Nardev earned his Ph.D. in clinical biochemistry from the University of Cambridge on an A*STAR Overseas Ph.D. scholarship. For his doctoral thesis, he identified a novel genetic mutation responsible for a rare inherited disease called lipodystrophy in a patient in the Middle East and went on to elucidate the molecular mechanism underlying the disease.
